Patent applications and USPTO patent grants for Warner Chilcott Company, LLC.The latest application filed is for "crystalline salts of (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-- methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same".
Patent | Date |
---|---|
5-aminosalicyclic acid capsule formulation Grant 10,265,273 - Boyd , et al. | 2019-04-23 |
Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability Grant 9,763,887 - Loughlin , et al. September 19, 2 | 2017-09-19 |
Crystalline Salts Of (4s, 4as, 5ar, 12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-- Methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic Acid Amide And Methods Of Using The Same App 20160200671 - COULTER; Catherine ;   et al. | 2016-07-14 |
Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(met- hyl)amino)-methyl] acid amide and methods of using the same Grant 9,255,068 - Coulter , et al. February 9, 2 | 2016-02-09 |
Low-dose Estradiol Cream App 20150258117 - deVries; Tina M. ;   et al. | 2015-09-17 |
Graduated estrogen contraceptive Grant 9,132,137 - Boissonneault September 15, 2 | 2015-09-15 |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures Grant 9,089,492 - Dittmar , et al. July 28, 2 | 2015-07-28 |
Compositions of azimilide dihydrochloride Grant 9,035,052 - Redman-Furey , et al. May 19, 2 | 2015-05-19 |
Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs Grant 8,962,010 - Woolfson , et al. February 24, 2 | 2015-02-24 |
Pharmaceutical Soft Gelatin Capsule Dosage Form With Modified Guar Gum App 20150044285 - MULDOON; Brendan ;   et al. | 2015-02-12 |
5-aminosalicylic Acid Capsule Formulation App 20140370083 - Boyd; Emma ;   et al. | 2014-12-18 |
Pharmaceutical Soft Gelatin Capsule Dosage Form App 20140271837 - MULDOON; Brendan ;   et al. | 2014-09-18 |
Mesalamine Pharmaceutical Composition With Multiple Dosage Elements For Reduced Delivery Variability App 20140271859 - LOUGHLIN; Ryan Gerald ;   et al. | 2014-09-18 |
Pharmaceutical Soft Gelatin Capsule Dosage Form With Modified Guar Gum App 20140271838 - MULDOON; Brendan ;   et al. | 2014-09-18 |
Bisphosphonate compounds Grant 8,822,435 - Ebetino , et al. September 2, 2 | 2014-09-02 |
Bisphosphonate Compounds App 20140194389 - Ebetino; Frank Hallock ;   et al. | 2014-07-10 |
Darifenacin for use in the treatment of urgency induced by overactive bladder Grant 8,748,476 - Colli , et al. June 10, 2 | 2014-06-10 |
5-aminosalicylic Acid Capsule Formulation App 20140141075 - Boyd; Emma ;   et al. | 2014-05-22 |
Bisphosphonate compounds Grant 8,710,215 - Ebetino , et al. April 29, 2 | 2014-04-29 |
Vitamin D content uniformity in pharmaceutical dosage forms Grant 8,703,187 - Dittmar , et al. April 22, 2 | 2014-04-22 |
Pharmaceutical Dosage Form with Multiple Coatings for Reduced Impact of Coating Fractures App 20140093576 - Dittmar; Gregory Paul ;   et al. | 2014-04-03 |
Dosage Forms Of Risedronate App 20140057872 - Dansereau; Richard John ;   et al. | 2014-02-27 |
Methods Of Using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(me- Thyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-- 2-carboxylic Acid Amide App 20130302442 - Coulter; Catherine ;   et al. | 2013-11-14 |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures Grant 8,580,302 - Dittmar , et al. November 12, 2 | 2013-11-12 |
Dosage forms of bisphosphonates Grant 8,535,718 - Dansereau , et al. September 17, 2 | 2013-09-17 |
Compositions Of Azimilide Dihydrochloride App 20130217701 - REDMAN-FUREY; Nancy Lee ;   et al. | 2013-08-22 |
Low Dosage Forms Of Risedronate Or Its Salts App 20130183353 - DANSEREAU; Richard John ;   et al. | 2013-07-18 |
Low Dosage Forms Of Risedronate Or Its Salts App 20130177645 - DANSEREAU; Richard John ;   et al. | 2013-07-11 |
Quadraphasis continuous graduated estrogen contraceptive Grant 8,461,138 - Boissonneault June 11, 2 | 2013-06-11 |
Doxycycline metal complex in a solid dosage form Grant 8,415,331 - deVries , et al. April 9, 2 | 2013-04-09 |
Low dosage forms of risedronate or its salts Grant 8,409,615 - Dansereau , et al. April 2, 2 | 2013-04-02 |
Low dosage forms of risedronate or its salts Grant 8,409,614 - Dansereau , et al. April 2, 2 | 2013-04-02 |
Bisphosphonate Compounds App 20130035482 - EBETINO; Frank Hallock ;   et al. | 2013-02-07 |
Dosage Forms Of Bisphosphonates App 20130012478 - DANSEREAU; RICHARD JOHN ;   et al. | 2013-01-10 |
Bisphosphonate compounds Grant 8,314,081 - Ebetino , et al. November 20, 2 | 2012-11-20 |
Dosage forms of bisphosphonates Grant 8,246,989 - Dansereau , et al. August 21, 2 | 2012-08-21 |
Compositions Of Azimilide Dihydrochloride App 20120178762 - REDMAN-FUREY; Nancy Lee ;   et al. | 2012-07-12 |
Compositions for Reducing the Incidence of Drug Induced Arrhythmia App 20120178724 - Sprafka, II; Joseph Michael ;   et al. | 2012-07-12 |
Method For Improving Compliance With A Treatment Regimen For Treating Or Preventing Osteoporosis App 20120145588 - Cawthray; Richard James ;   et al. | 2012-06-14 |
Compositions for reducing the incidence of drug induced arrhythmia Grant 8,183,284 - Sprafka, II , et al. May 22, 2 | 2012-05-22 |
Dosage Forms Of Risedronate App 20120094960 - Dansereau; Richard John ;   et al. | 2012-04-19 |
Graduated estrogen contraceptive Grant 8,124,595 - Boissonneault February 28, 2 | 2012-02-28 |
Human protein tyrosine phosphatase inhibitors and methods of use Grant 8,106,078 - Gray , et al. January 31, 2 | 2012-01-31 |
Extended cycle multiphasic oral contraceptive method Grant 8,063,030 - Ellman November 22, 2 | 2011-11-22 |
Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-meth- oxy-4-oxo-3-quinolinecarboxylic acid Grant 8,039,485 - Redman-Furey , et al. October 18, 2 | 2011-10-18 |
Compositions Of Azimilide Dihydrochloride App 20110237603 - REDMAN-FUREY; Nancy Lee | 2011-09-29 |
Extended cycle multiphasic oral contraceptive kit Grant 7,935,691 - Boissonneault May 3, 2 | 2011-05-03 |
Bisphosphonate Compounds App 20110098251 - Ebetino; Frank Hallock ;   et al. | 2011-04-28 |
Graduated Estrogen Contraceptive App 20110059928 - Boissonneault; Roger M. | 2011-03-10 |
Corticotropin releasing factor 2 receptor agonists Grant 7,897,731 - Isfort , et al. March 1, 2 | 2011-03-01 |
Antimicrobial quinolones, their compositions and uses Grant 7,868,021 - Ledoussal , et al. January 11, 2 | 2011-01-11 |
Prolyl hydroxylase inhibitors and methods of use Grant 7,811,595 - Kawamoto , et al. October 12, 2 | 2010-10-12 |
Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation Grant 7,799,771 - Aloba , et al. September 21, 2 | 2010-09-21 |
Derivative prodrugs of ethinyl estradiol Grant 7,795,241 - Keown , et al. September 14, 2 | 2010-09-14 |
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones Grant 7,790,748 - Warshakoon , et al. September 7, 2 | 2010-09-07 |
Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar App 20100210605 - Kaczanowski; Matthew John ;   et al. | 2010-08-19 |
Extended Estrogen Dosing Contraceptive Regimen App 20100168071 - Boissonneault; Roger M. | 2010-07-01 |
Dosage Forms Of Risedronate App 20100119559 - DANSEREAU; RICHARD JOHN ;   et al. | 2010-05-13 |
Low Dosage Forms Of Risedronate Or Its Salts App 20100113394 - DANSEREAU; RICHARD JOHN ;   et al. | 2010-05-06 |
Low Dosage Forms Of Risedronate Or Its Salts App 20100113395 - DANSEREAU; RICHARD JOHN ;   et al. | 2010-05-06 |
Extended estrogen dosing contraceptive regimen Grant 7,704,984 - Boissonneault April 27, 2 | 2010-04-27 |
Dosage Forms Of Bisphosphonates App 20100086593 - Dansereau; Richard John ;   et al. | 2010-04-08 |
Extended Cycle Multiphasic Oral Contraceptive Kit App 20090291927 - BOISSONNEAULT; ROGER M. | 2009-11-26 |
Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation Grant 7,572,779 - Aloba , et al. August 11, 2 | 2009-08-11 |
Extended cycle multiphasic oral contraceptive method Grant 7,569,560 - Boissonneault August 4, 2 | 2009-08-04 |
SEC | 0001319903 | Warner Chilcott Company, LLC of PUERTO RICO |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.